Energy balance

Administration of the mitochondria-targeted protonophore C12TPP reduces body fat and weight in high-fat-diet-induced obese mice by increasing resting metabolic rate and enhancing fatty acid oxidation, independent of UCP1.

This research suggests that targeting mitochondria with specific compounds like C12TPP can reduce body fat by increasing the body's resting energy expenditure and burning more fat, even without changing food intake. This effect was most pronounced in a warm environment (thermoneutrality) and did not rely on the classic brown fat protein UCP1. While promising in mice, this is a pharmacological intervention not currently available or recommended for human weight loss.